WC
NPTN

Wexford Capital’s NEOPHOTONICS CORP NPTN Stock Holding History

Wexford Capital’s Portfolio NPTN Stock Details NPTN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-34,900
Closed -$146K – 164
2019
Q2 		$146K Buy
+34,900
New +$184K 0.02% 113

Other funds holding NPTN

Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Wexford Capital's NPTN Position: Q3 2019 in Review

Wexford Capital sold out of NEOPHOTONICS CORP (NPTN) in Q3 2019, closing a stake of 34,900 shares — an estimated $146K sold.

Wexford Capital first reported a position in NPTN in Q2 2019 and held it in 1 quarter. The position peaked at $146K in Q2 2019. 116 funds tracked by Wall St. Rank hold NPTN as of Q3 2019.

  • Wexford Capital reported no remaining NEOPHOTONICS CORP position as of Q3 2019 after selling out during the quarter.
  • Wexford Capital sold 34,900 NEOPHOTONICS CORP shares in Q3 2019, an estimated $146K.
  • Wexford Capital first reported a position in NEOPHOTONICS CORP in Q2 2019 and held it in 1 quarter.
  • Wexford Capital's NEOPHOTONICS CORP position peaked at $146K in Q2 2019.
  • 116 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q3 2019.

Based on Wexford Capital's 13F filing for Q3 2019, filed 14 Nov 2019.